Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000729298 | SCV000856947 | uncertain significance | not provided | 2017-09-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000791996 | SCV000931267 | uncertain significance | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7; Autosomal recessive limb-girdle muscular dystrophy type 2U | 2020-07-12 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with ISPD-related disease. This variant is present in population databases (rs762217429, ExAC 0.01%). This sequence change replaces alanine with threonine at codon 398 of the ISPD protein (p.Ala398Thr). The alanine residue is moderately conserved and there is a small physicochemical difference between alanine and threonine. |